Browse by Nurse Practitioner Items

Nurse practitioner PBS prescribing

MEDICINES WHICH MAY BE PRESCRIBED BY AUTHORISED NURSE PRACTITIONERS

From 1 September 2010, nurse practitioners endorsed to prescribe under state or territory legislation can apply for approval as PBS prescribers (authorised nurse practitioners) Information for nurse practitioners to become authorised PBS prescribers is available from the Department of Human Services.

The medicines listed for prescribing by authorised nurse practitioners from 1 November 2010 are identified by ‘NP’ in the PBS Schedule. Nurse practitioners must not write PBS prescriptions for other medicines.

PBS prescribing is limited by a nurse practitioner’s scope of practice, and state and territory prescribing rights. Prescribing of PBS medicines is also contingent on a prescriber being an authorised nurse practitioner and having collaborative arrangements in place, as required by amendments to the National Health Act 1953.

The Pharmaceutical Benefits Advisory Committee (PBAC) is responsible for making recommendations to the Minister for Health regarding medicines for prescribing by authorised nurse practitioners.

Further to prescribing within collaborative arrangements, certain medicines also have additional conditions for prescribing by nurse practitioners, as recommended by the PBAC. These medicines are identified by the codes ‘CTO’ for continuation therapy only or ‘SCM’ for prescribing within a shared care model, as outlined below:

  • Continuing therapy only model

Where the patient’s treatment and prescribing of a medicine has been initiated by a medical practitioner, but prescribing is continued by a nurse practitioner. (This is similar to existing arrangements between specialists and medical practitioners for prescribing certain medicines.)

  • Shared care model

Where care is shared between a nurse practitioner and medical practitioner in a formalised arrangement with an agreed plan to manage the patient, in a patientcentred model of care. The details surrounding shared care arrangements will depend on the practitioners involved, patient needs and the healthcare context.

Some medicines are included in more than one section of the Schedule, and for more than one prescriber type. For a prescription to be eligible for subsidy, prescribers must ensure that they prescribe under the PBS only those medicines, and in accordance with the restrictions, listed for their prescriber type. Listing details for the same product may differ between sections and different PBS item codes apply for each prescriber type.

Nurse practitioner PBS prescriptions are identifiable by colour, and include the indicator ‘NP’ on personalised forms and a tick box on non-personalised (blank) forms.

Prescriptions must include the nurse practitioner’s PBS prescriber number. For unrestricted and restricted PBS medicines, midwives/nurse practitioners can use the personalised or non-personalised PBS prescriber forms.  For authority required and authority required (streamlined) PBS medicines, midwives/nurse practitioners can use the authority personalised or non-personalised PBS prescriber forms.  Nurse practitioner PBS prescriptions may include repeats. 

Regulation 49 applies for nurse practitioner prescribing. A nurse practitioner can direct that original and repeat supplies of pharmaceutical benefits be supplied at the one time, if certain conditions are satisfied.

Authority prescriptions: Authority prescriptions for authority required items, or for increased quantities or repeats, require prior approval from the Department of Human Services for each prescription. (Refer to Prescribing Medicines — Information for PBS prescribers and Supplying medicines — What Pharmacists Need to Know, for more information on authority prescriptions.)

State and territory requirements: Nurse practitioners may prescribe medicines as private prescriptions according to their state/territory prescribing accreditation. The medicines which can be prescribed differ between states and territories. It is the nurse practitioner’s responsibility to ensure adherence to State/Territory law for all prescriptions (PBS and private) and additionally to all PBS requirements for PBS prescriptions.

  • Legend
  • PPalliative care items
  • MPMedical Practitioner
  • MWMidwife
  • NPNurse Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MPNP 3416T MACROGOL-3350macrogol-3350 1 g/g powder for oral liquid, 510 g 1 1 5
MPNP 5426N MACROGOL-3350macrogol-3350 1 g/g powder for oral liquid, 510 g 2 2 3
MPNP 2351R MACROGOL-3350macrogol-3350 1 g/g oral liquid: powder for, 30 x 17 g sachets 2 2 3
MPNP 2373X MACROGOL-3350macrogol-3350 1 g/g oral liquid: powder for, 30 x 17 g sachets 1 1 5
MPNP 5389P MACROGOL-3350 + SODIUM CHLORIDE + BICARBONATE + POTASSIUM CHLORIDEmacrogol-3350 13.12 g + sodium chloride 350.7 mg + potassium chloride 46.6 mg (0.63 mmol potassium) + sodium bicarbonate 178.5 mg solution, 30 sachets 2 2 3
MPNP 8612G MACROGOL-3350 + SODIUM CHLORIDE + BICARBONATE + POTASSIUM CHLORIDEmacrogol-3350 13.12 g + sodium chloride 350.7 mg + potassium chloride 46.6 mg (0.63 mmol potassium) + sodium bicarbonate 178.5 mg solution, 30 sachets 1 1 5
MPNP 10126Y MACROGOL-3350 + SODIUM CHLORIDE + BICARBONATE + POTASSIUM CHLORIDEmacrogol-3350 13.12 g/25 mL + sodium chloride 350.7 mg/25 mL + potassium chloride 46.6 mg/25 mL (0.63 mmol/25 mL potassium) + sodium bicarbonate 178.5 mg/25 mL oral liquid, 500 mL 2 2 5
MPNP 10127B MACROGOL-3350 + SODIUM CHLORIDE + BICARBONATE + POTASSIUM CHLORIDEmacrogol-3350 13.12 g/25 mL + sodium chloride 350.7 mg/25 mL + potassium chloride 46.6 mg/25 mL (0.63 mmol/25 mL potassium) + sodium bicarbonate 178.5 mg/25 mL oral liquid, 500 mL 2 2 3
MPNP 5146W MAGNESIUM ASPARTATE DIHYDRATEmagnesium aspartate dihydrate 500 mg (magnesium 37.4 mg) tablet, 50 1 50 5
MPNP 3128P MEDIUM CHAIN TRIGLYCERIDESmedium chain triglycerides oral oil, 500 mL 2 2 5
MPNP 11444H MEDIUM CHAIN TRIGLYCERIDESmedium chain triglycerides oral liquid, 15 x 225 mL bottles 2 2 5
MPNP 9327X MEDIUM CHAIN TRIGLYCERIDESmedium chain triglycerides oral liquid, 250 mL bottle 8 8 5
MPNP 2321E MEDROXYPROGESTERONEmedroxyprogesterone acetate 10 mg tablet, 30 1 30 2
MPNP 2323G MEDROXYPROGESTERONEmedroxyprogesterone acetate 5 mg tablet, 56 1 56 2
MPNP 3118D MEDROXYPROGESTERONEmedroxyprogesterone acetate 150 mg/mL injection, 1 mL vial 1 1 1
MPNP 1824B MEFENAMIC ACIDmefenamic acid 250 mg capsule, 50 1 50 2
MPNP 8562P MELOXICAMmeloxicam 15 mg tablet, 30 1 30 3
MPNP 8888T MELOXICAMmeloxicam 15 mg capsule, 30 1 30 3
MPNP 8887R MELOXICAMmeloxicam 7.5 mg capsule, 30 1 30 3
MPNP 8561N MELOXICAMmeloxicam 7.5 mg tablet, 30 1 30 3
MPNP 2513G MEMANTINEmemantine hydrochloride 20 mg tablet, 28 1 28 5
MPNP 9306T MEMANTINEmemantine hydrochloride 20 mg tablet, 28 1 28 5
MPNP 1956Y MEMANTINEmemantine hydrochloride 10 mg tablet, 56 1 56 5
MPNP 2492E MEMANTINEmemantine hydrochloride 10 mg tablet, 56 1 56 5
MPNP 11554D MESALAZINEmesalazine 1 g enteric tablet, 60 2 120 5
MPNP 2214M MESALAZINEmesalazine 500 mg modified release tablet, 100 2 200 5
MPNP 10254Q MESALAZINEmesalazine 4 g modified release granules, 30 sachets 1 30 5
MPNP 5461K MESALAZINEmesalazine 1 g suppository, 30 1 30 1
MPNP 8752P MESALAZINEmesalazine 1 g suppository, 30 1 30 1
MPNP 1611T MESALAZINEmesalazine 250 mg enteric tablet, 100 1 100 5
MPNP 9206M MESALAZINEmesalazine 1.5 g modified release granules, 60 sachets 1 60 5
MPNP 11210B MESALAZINEmesalazine 800 mg enteric tablet, 90 2 180 5
MPNP 8616L MESALAZINEmesalazine 2 g/60 mL enema, 7 x 60 mL 4 4 1
MPNP 8731M MESALAZINEmesalazine 500 mg enteric tablet, 100 2 200 5
MPNP 8617M MESALAZINEmesalazine 4 g/60 mL enema, 7 x 60 mL 4 4 1
MPNP 8598M MESALAZINEmesalazine 500 mg modified release granules, 100 sachets 2 200 5
MPNP 2234N MESALAZINEmesalazine 1 g modified release granules, 120 sachets 1 120 5
MPNP 2287J MESALAZINEmesalazine 2 g modified release granules, 60 sachets 1 60 5
MPNP 3413P MESALAZINEmesalazine 1 g modified release tablet, 60 2 120 5
MPNP 8753Q MESALAZINEmesalazine 1 g/100 mL enema, 7 x 100 mL 4 4 1
MPNP 8599N MESALAZINEmesalazine 1 g modified release granules, 100 sachets 1 100 5
MPNP 10257W MESALAZINEmesalazine 3 g modified release granules, 30 sachets 1 30 5
MPNP 9353G MESALAZINEmesalazine 1.2 g modified release tablet, 60 2 120 5
MPNP 8768L MESALAZINEmesalazine 1 g/application enema, 14 applications 4 4 1
MPNP 8607B METFORMINmetformin hydrochloride 1 g tablet, 90 1 90 5
MPNP 3439B METFORMINmetformin hydrochloride 1 g modified release tablet, 60 1 60 5
MPNP 9435N METFORMINmetformin hydrochloride 500 mg modified release tablet, 120 1 120 5
MPNP 2430X METFORMINmetformin hydrochloride 500 mg tablet, 100 1 100 5
MPNP 1801T METFORMINmetformin hydrochloride 850 mg tablet, 60 1 60 5
MPNP 8811R METFORMIN + GLIBENCLAMIDEmetformin hydrochloride 500 mg + glibenclamide 5 mg tablet, 90 1 90 5
MPNP 8838E METFORMIN + GLIBENCLAMIDEmetformin hydrochloride 250 mg + glibenclamide 1.25 mg tablet, 90 1 90 5
MPNP 8810Q METFORMIN + GLIBENCLAMIDEmetformin hydrochloride 500 mg + glibenclamide 2.5 mg tablet, 90 1 90 5
MPNP 6172W METHADONEmethadone hydrochloride 5 mg/mL oral liquid, 1 L 1 1 0
MPNP 1609Q METHADONEmethadone hydrochloride 10 mg tablet, 20 1 20 0
MPNP 5399E METHADONEmethadone hydrochloride 5 mg/mL oral liquid, 200 mL 1 1 2
MPNP 5400F METHADONEmethadone hydrochloride 5 mg/mL oral liquid, 200 mL 1 1 0
MPNP 6171T METHADONEmethadone hydrochloride 5 mg/mL oral liquid, 200 mL 1 1 0
MPNP 1606M METHADONEmethadone hydrochloride 10 mg/mL injection, 5 x 1 mL ampoules 1 5 0
MPNP 3124K METHENAMINE HIPPURATEmethenamine hippurate 1 g tablet, 100 1 100 5
MPNP 1629R METHYLDOPAmethyldopa 250 mg tablet, 100 1 100 5
MPNP 5423K METHYLNALTREXONEmethylnaltrexone bromide 12 mg/0.6 mL injection, 0.6 mL vial 7 7 0
MPNP 5424L METHYLNALTREXONEmethylnaltrexone bromide 12 mg/0.6 mL injection, 7 x 0.6 mL vials 1 7 0
MPNP 2280B METHYLPHENIDATEmethylphenidate hydrochloride 30 mg modified release capsule, 30 1 30 5
MPNP 2283E METHYLPHENIDATEmethylphenidate hydrochloride 40 mg modified release capsule, 30 1 30 5
MPNP 2276T METHYLPHENIDATEmethylphenidate hydrochloride 20 mg modified release capsule, 30 1 30 5
MPNP 2387P METHYLPHENIDATEmethylphenidate hydrochloride 18 mg modified release tablet, 30 1 30 5
MPNP 2432B METHYLPHENIDATEmethylphenidate hydrochloride 54 mg modified release tablet, 30 1 30 5
MPNP 8839F METHYLPHENIDATEmethylphenidate hydrochloride 10 mg tablet, 100 1 100 5
MPNP 2172H METHYLPHENIDATEmethylphenidate hydrochloride 27 mg modified release tablet, 30 1 30 5
MPNP 2388Q METHYLPHENIDATEmethylphenidate hydrochloride 36 mg modified release tablet, 30 1 30 5
MPNP 3440C METHYLPHENIDATEmethylphenidate hydrochloride 10 mg modified release capsule, 30 1 30 5
MPNP 10830B METHYLPREDNISOLONEmethylprednisolone aceponate 0.1% lotion, 20 g 5 5 5
MPNP 10838K METHYLPREDNISOLONEmethylprednisolone aceponate 0.1% lotion, 20 g 3 3 5
MPNP 10852E METHYLPREDNISOLONEmethylprednisolone aceponate 0.1% lotion, 20 g 4 4 5
MPNP 10856J METHYLPREDNISOLONEmethylprednisolone aceponate 0.1% lotion, 20 g 2 2 5
MPNP 8618N METHYLPREDNISOLONEmethylprednisolone aceponate 0.1% lotion, 20 g 1 1 0
MPNP 10833E METHYLPREDNISOLONEmethylprednisolone aceponate 0.1% cream, 15 g 10 10 5
MPNP 10835G METHYLPREDNISOLONEmethylprednisolone aceponate 0.1% cream, 15 g 6 6 5
MPNP 10842P METHYLPREDNISOLONEmethylprednisolone aceponate 0.1% cream, 15 g 2 2 5
MPNP 10851D METHYLPREDNISOLONEmethylprednisolone aceponate 0.1% cream, 15 g 8 8 5
MPNP 10855H METHYLPREDNISOLONEmethylprednisolone aceponate 0.1% cream, 15 g 4 4 5
MPNP 8054X METHYLPREDNISOLONEmethylprednisolone aceponate 0.1% cream, 15 g 1 1 0
MPNP 1928L METHYLPREDNISOLONEmethylprednisolone acetate 40 mg/mL injection, 5 x 1 mL vials 1 5 0
MPNP 2981X METHYLPREDNISOLONEmethylprednisolone 40 mg injection [5 vials] (&) inert substance diluent [5 x 1 mL vials], 1 pack 1 5 0
MPNP 5264C METHYLPREDNISOLONEmethylprednisolone 1 g injection, 1 vial 1 1 0
MPNP 5263B METHYLPREDNISOLONEmethylprednisolone 40 mg injection, 5 vials 1 5 0
MPNP 10834F METHYLPREDNISOLONEmethylprednisolone aceponate 0.1% ointment, 15 g 8 8 5
MPNP 10836H METHYLPREDNISOLONEmethylprednisolone aceponate 0.1% ointment, 15 g 4 4 5
MPNP 10845T METHYLPREDNISOLONEmethylprednisolone aceponate 0.1% ointment, 15 g 10 10 5
MPNP 10846W METHYLPREDNISOLONEmethylprednisolone aceponate 0.1% ointment, 15 g 2 2 5
MPNP 10853F METHYLPREDNISOLONEmethylprednisolone aceponate 0.1% ointment, 15 g 6 6 5
MPNP 8055Y METHYLPREDNISOLONEmethylprednisolone aceponate 0.1% ointment, 15 g 1 1 0
MPNP 10839L METHYLPREDNISOLONEmethylprednisolone aceponate 0.1% ointment: fatty, 15 g 8 8 5
MPNP 10840M METHYLPREDNISOLONEmethylprednisolone aceponate 0.1% ointment: fatty, 15 g 4 4 5
MPNP 10843Q METHYLPREDNISOLONEmethylprednisolone aceponate 0.1% ointment: fatty, 15 g 10 10 5
MPNP 10844R METHYLPREDNISOLONEmethylprednisolone aceponate 0.1% ointment: fatty, 15 g 6 6 5
MPNP 10848Y METHYLPREDNISOLONEmethylprednisolone aceponate 0.1% ointment: fatty, 15 g 2 2 5
MPNP 8128T METHYLPREDNISOLONEmethylprednisolone aceponate 0.1% ointment: fatty, 15 g 1 1 0
MPMWNP 1207M METOCLOPRAMIDEmetoclopramide hydrochloride 10 mg tablet, 25 1 25 0
MPNP 10762K METOCLOPRAMIDEmetoclopramide hydrochloride 10 mg/2 mL injection, 10 x 2 mL ampoules 4 40 0
MPMWNP 1206L METOCLOPRAMIDEmetoclopramide hydrochloride 10 mg/2 mL injection, 10 x 2 mL ampoules 1 10 0
MPNP 3476Y METOCLOPRAMIDEmetoclopramide hydrochloride 10 mg/2 mL injection, 10 x 2 mL ampoules 1 10 0
MPNP 8733P METOPROLOL SUCCINATEMETOPROLOL SUCCINATE Tablet 47.5 mg (controlled release), 30 1 30 5
MPNP 8735R METOPROLOL SUCCINATEMETOPROLOL SUCCINATE Tablet 190 mg (controlled release), 30 1 30 5
MPNP 8734Q METOPROLOL SUCCINATEMETOPROLOL SUCCINATE Tablet 95 mg (controlled release), 30 1 30 5
MPNP 8732N METOPROLOL SUCCINATEMETOPROLOL SUCCINATE Tablet 23.75 mg (controlled release), 15 1 15 0
MPNP 1325R METOPROLOL TARTRATEMETOPROLOL TARTRATE Tablet 100 mg, 60 1 60 5
MPNP 1324Q METOPROLOL TARTRATEMETOPROLOL TARTRATE Tablet 50 mg, 100 1 100 5
MPNP 1642K METRONIDAZOLEmetronidazole 500 mg suppository, 10 1 1 0
MPNP 1630T METRONIDAZOLEmetronidazole 200 mg/5 mL oral liquid, 100 mL 1 1 0
MPNP 1636D METRONIDAZOLEmetronidazole 200 mg tablet, 21 1 21 1
MPNP 1621H METRONIDAZOLEmetronidazole 400 mg tablet, 21 1 21 1
MPNP 1628Q MIANSERINmianserin hydrochloride 20 mg tablet, 50 1 50 5
MPNP 1627P MIANSERINmianserin hydrochloride 10 mg tablet, 50 1 50 5
MPNP 9029F MICONAZOLEmiconazole nitrate 2% dusting powder, 30 g 1 1 2
MPNP 9027D MICONAZOLEmiconazole nitrate 2% cream, 30 g 1 1 2
MPNP 9028E MICONAZOLEmiconazole nitrate 2% cream, 70 g 1 1 1
MPNP 9031H MICONAZOLEmiconazole 2% solution, 30 mL 1 1 2
MPNP 10178Q MIDAZOLAMmidazolam 5 mg/mL injection, 10 x 1 mL ampoules 1 10 0
MPNP 11209Y MILK POWDER LACTOSE INTOLERANCE FORMULAmilk powder lactose intolerance formula powder for oral liquid, 900 g 5 5 0
MPNP 3092R MILK POWDER SYNTHETIC LOW CALCIUMmilk powder synthetic low calcium powder for oral liquid, 400 g 8 8 5
MPNP 8630F MILK PROTEIN AND FAT FORMULA WITH VITAMINS AND MINERALS CARBOHYDRATE FREEmilk protein and fat formula with vitamins and minerals carbohydrate free powder for oral liquid, 225 g 24 24 5
MPNP 1616C MINOCYCLINEminocycline 50 mg tablet, 60 1 60 5
MPNP 2313R MINOXIDILminoxidil 10 mg tablet, 100 1 100 5
MPNP 8513C MIRTAZAPINEmirtazapine 30 mg tablet, 30 1 30 5
MPNP 8857E MIRTAZAPINEmirtazapine 45 mg orally disintegrating tablet, 30 1 30 5
MPNP 9365X MIRTAZAPINEmirtazapine 15 mg tablet, 30 1 30 5
MPNP 8856D MIRTAZAPINEmirtazapine 30 mg orally disintegrating tablet, 30 1 30 5
MPNP 8855C MIRTAZAPINEmirtazapine 15 mg orally disintegrating tablet, 30 1 30 5
MPNP 8883M MIRTAZAPINEmirtazapine 45 mg tablet, 30 1 30 5
MPNP 8003F MOCLOBEMIDEmoclobemide 300 mg tablet, 60 1 60 5
MPNP 1900B MOCLOBEMIDEmoclobemide 150 mg tablet, 60 1 60 5
MPNP 9386B MODIFIED LONG CHAIN AMYLOPECTINmodified long chain amylopectin powder for oral liquid, 30 x 60 g sachets 4 4 5
MPNP 10792B MOMETASONEmometasone furoate 0.1% cream, 15 g 10 10 5
MPNP 10809X MOMETASONEmometasone furoate 0.1% cream, 15 g 4 4 5
MPNP 10815F MOMETASONEmometasone furoate 0.1% cream, 15 g 6 6 5
MPNP 10818J MOMETASONEmometasone furoate 0.1% cream, 15 g 8 8 5
MPNP 10827W MOMETASONEmometasone furoate 0.1% cream, 15 g 2 2 5
MPNP 1913Q MOMETASONEmometasone furoate 0.1% cream, 15 g 1 1 0
MPNP 10804P MOMETASONEmometasone furoate 0.1% lotion, 30 mL 5 5 5
MPNP 10805Q MOMETASONEmometasone furoate 0.1% lotion, 30 mL 4 4 5
MPNP 10819K MOMETASONEmometasone furoate 0.1% lotion, 30 mL 2 2 5
MPNP 10826T MOMETASONEmometasone furoate 0.1% lotion, 30 mL 3 3 5
MPNP 8043H MOMETASONEmometasone furoate 0.1% lotion, 30 mL 1 1 0
MPNP 10791Y MOMETASONEmometasone furoate 0.1% ointment, 15 g 10 10 5
MPNP 10793C MOMETASONEmometasone furoate 0.1% ointment, 15 g 8 8 5
MPNP 10812C MOMETASONEmometasone furoate 0.1% ointment, 15 g 2 2 5
MPNP 10814E MOMETASONEmometasone furoate 0.1% ointment, 15 g 4 4 5
MPNP 10828X MOMETASONEmometasone furoate 0.1% ointment, 15 g 6 6 5
MPNP 1915T MOMETASONEmometasone furoate 0.1% ointment, 15 g 1 1 0
MPNP 8627C MONTELUKASTmontelukast 4 mg chewable tablet, 28 1 28 5
MPNP 8628D MONTELUKASTmontelukast 5 mg chewable tablet, 28 1 28 5
MPNP 10862Q MORPHINEmorphine hydrochloride trihydrate 10 mg/mL injection, 5 x 1 mL ampoules 1 5 0
MPMWNP 10864T MORPHINEmorphine hydrochloride trihydrate 10 mg/mL injection, 5 x 1 mL ampoules 1 5 0
MPNP 10869C MORPHINEmorphine hydrochloride trihydrate 50 mg/5 mL injection, 5 x 5 mL ampoules 1 5 0
MPNP 5391R MORPHINEmorphine sulfate pentahydrate 200 mg modified release tablet, 28 1 28 2
MPNP 8453X MORPHINEmorphine sulfate pentahydrate 200 mg modified release tablet, 28 1 28 0
MPNP 1654C MORPHINEmorphine sulfate pentahydrate 30 mg modified release tablet, 28 1 28 0
MPNP 1647Q MORPHINEmorphine sulfate pentahydrate 30 mg/mL injection, 5 x 1 mL ampoules 1 5 0
MPNP 3480E MORPHINEmorphine sulfate pentahydrate 30 mg/mL injection, 5 x 1 mL ampoules 1 5 0
MPNP 1653B MORPHINEmorphine sulfate pentahydrate 10 mg modified release tablet, 28 1 28 0
MPNP 2122Q MORPHINEmorphine hydrochloride trihydrate 2 mg/mL oral liquid, 200 mL 1 1 0
MPNP 5394X MORPHINEmorphine sulfate pentahydrate 20 mg tablet, 20 1 20 2
MPNP 8670H MORPHINEmorphine sulfate pentahydrate 20 mg tablet, 20 1 20 0
MPNP 5393W MORPHINEmorphine sulfate pentahydrate 10 mg tablet, 20 1 20 2
MPNP 8669G MORPHINEmorphine sulfate pentahydrate 10 mg tablet, 20 1 20 0
MPNP 2123R MORPHINEmorphine hydrochloride trihydrate 5 mg/mL oral liquid, 200 mL 1 1 0
MPNP 8146R MORPHINEmorphine sulfate pentahydrate 30 mg modified release granules, 28 sachets 1 28 0
MPNP 10868B MORPHINEmorphine hydrochloride trihydrate 20 mg/mL injection, 5 x 1 mL ampoules 1 5 0
MPNP 10874H MORPHINEmorphine hydrochloride trihydrate 20 mg/mL injection, 5 x 1 mL ampoules 1 5 0
MPNP 8491X MORPHINEmorphine sulfate pentahydrate 30 mg modified release capsule, 14 1 14 0
MPNP 2841M MORPHINEmorphine sulfate pentahydrate 100 mg modified release capsule, 28 1 28 0
MPNP 2124T MORPHINEmorphine hydrochloride trihydrate 10 mg/mL oral liquid, 200 mL 1 1 0
MPNP 8492Y MORPHINEmorphine sulfate pentahydrate 60 mg modified release capsule, 14 1 14 0
MPNP 8490W MORPHINEmorphine sulfate pentahydrate 20 mg modified release granules, 28 sachets 1 28 0
MPNP 8306E MORPHINEmorphine sulfate pentahydrate 100 mg modified release granules, 28 sachets 1 28 0
MPNP 1607N MORPHINEmorphine tartrate 120 mg/1.5 mL injection, 5 x 1.5 mL ampoules 1 5 0
MPNP 8349K MORPHINEmorphine sulfate pentahydrate 10 mg modified release capsule, 28 1 28 0
MPNP 1655D MORPHINEmorphine sulfate pentahydrate 60 mg modified release tablet, 28 1 28 0
MPNP 8454Y MORPHINEmorphine sulfate pentahydrate 200 mg modified release granules, 28 sachets 1 28 0
MPNP 2839K MORPHINEmorphine sulfate pentahydrate 20 mg modified release capsule, 28 1 28 0
MPMWNP 1645N MORPHINEmorphine sulfate pentahydrate 15 mg/mL injection, 5 x 1 mL ampoules 1 5 0
MPNP 3479D MORPHINEmorphine sulfate pentahydrate 15 mg/mL injection, 5 x 1 mL ampoules 1 5 0
MPNP 8489T MORPHINEmorphine sulfate pentahydrate 15 mg modified release tablet, 28 1 28 0
MPNP 8035X MORPHINEmorphine sulfate pentahydrate 5 mg modified release tablet, 28 1 28 0
MPNP 1656E MORPHINEmorphine sulfate pentahydrate 100 mg modified release tablet, 28 1 28 0
MPMWNP 1644M MORPHINEmorphine sulfate pentahydrate 10 mg/mL injection, 5 x 1 mL ampoules 1 5 0
MPNP 1646P MORPHINEmorphine sulfate pentahydrate 30 mg tablet, 20 1 20 0
MPNP 8494C MORPHINEmorphine sulfate pentahydrate 120 mg modified release capsule, 14 1 14 0
MPNP 8305D MORPHINEmorphine sulfate pentahydrate 60 mg modified release granules, 28 sachets 1 28 0
MPNP 8493B MORPHINEmorphine sulfate pentahydrate 90 mg modified release capsule, 14 1 14 0
MPNP 2840L MORPHINEmorphine sulfate pentahydrate 50 mg modified release capsule, 28 1 28 0
MPNP 10878M MORPHINEmorphine hydrochloride trihydrate 100 mg/5 mL injection, 5 x 5 mL ampoules 1 5 0
MPNP 9019Q MOXONIDINEmoxonidine 200 microgram tablet, 30 1 30 5
MPNP 9020R MOXONIDINEmoxonidine 400 microgram tablet, 30 1 30 5
MPNP 9440W MUPIROCINmupirocin 2% (20 mg/g) ointment, 3 g 1 1 0